产品名称
铼, wire reel, 0.05m, diameter 0.5mm, annealed, 99.97%
InChI
1S/Re
SMILES string
[ReH]
InChI key
WUAPFZMCVAUBPE-UHFFFAOYSA-N
assay
≥99.97%
form
wire
manufacturer/tradename
Goodfellow 942-224-58
bp
5596 °C (lit.)
5627 °C (lit.)
mp
3180 °C (lit.)
density
21.02 g/cm3 (lit.)
正在寻找类似产品? 访问 产品对比指南
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
法规信息
新产品
此项目有
Peter Wolohan et al.
Steroids, 72(3), 247-260 (2007-02-07)
OPLS all atom force field parameters were developed in order to model a diverse set of novel rhenium based estrogen receptor ligands whose relative binding affinities (RBA) to the estrogen receptor alpha isoform (ERalpha) with respect to 17beta-estradiol were available.
R Klett et al.
Rheumatology (Oxford, England), 46(10), 1531-1537 (2007-06-29)
Hypertrophy and inflammation of the synovium with various underlying pathologies - such as rheumatoid arthritis, osteoarthritis, haemophilia and spondyloarthropathy - can be treated successfully by radiosynoviorthesis (RSO). For medium-sized joints (shoulder, elbow, wrist, hip and ankle), the radionuclide of choice
Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium.
G L Griffiths et al.
Bioconjugate chemistry, 3(2), 91-99 (1992-03-01)
Malcolm Frier
Mini reviews in medicinal chemistry, 4(1), 61-68 (2004-02-03)
The favourable nuclear properties of copper-67 and rhenium-188 for therapeutic application are described, together with methods for the chemical synthesis of a number of derivatives. Survival from invasive bladder cancer has changed little over the past 20 years. The intravesicular
B Lambert et al.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 53(3), 305-310 (2009-06-13)
Rhenium-188 (188Re) is a high energy beta-emitter with a physical half life of 17 hours. Various 188Re based radiopharmaceuticals were developed to treat liver malignancies. The vast majority of studies focus on patients suffering from hepatocellular carcinoma (HCC). Most radiopharmaceuticals
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持